WHO 预认证部门发布第42次原料药意向书邀请，新增羟基脲原料药

Skip to main content

• Contact us

  • General contacts
  • Inmunization devices key contacts
  • In Vitro Diagnostics Key Contacts
  • Vaccines Key Contacts
  • Medical Devices Key Contacts
  • Medicines Key Contacts
  • Vector Control Products Key Contacts
  • Inspection Services Key Contacts

• Glossary and Acronyms

• FAQ

• Complaints

• Feedback

Main Menu Level 1

Home

Product Streams

Immunization Devices

In Vitro Diagnostics

Medical Devices

Medicines

Vaccines

Vector Control Products

Inspection Services

Events

News

eCTD

ePQS

About

Search

Search

Immunization Devices Stream Menu

• About Immunization Devices Prequalification
• What We Do
• Documents A-Z
• WHO Catalogue of Prequalified Immunization Devices
• WHO Product Standards for Immunization Devices
• Procuring Prequalified Products
• Prequalification Procedures & Fees
• Product Testing Support for Manufacturers
• Post-prequalification Commitments and Fees
• Post-market Monitoring
• Laboratory Accreditation for Product Testing
• Product testing support for laboratories
• Guidance Documents
• Market Information

In Vitro Diagnostics Stream Menu

• About In Vitro Diagnostic & Medical Devices Prequalification
• What We Do
• Documents A-Z
• Prequalified In Vitro Diagnostics
• Prequalified Male Circumcision Devices
• In Vitro Diagnostics Under Assessment
• IVDs Eligible for WHO Prequalification
• Prequalification Procedures & Fees: IVDs
• Post-prequalification Procedures & Fees: Prequalified IVDs
• Prequalification Reports
• Collaborative Procedure for Accelerated Registration
• Guidance Documents
• Support to Manufacturers
• Emergency Use Listing Procedure
• Expert Review Panel for Diagnostics
• Performance evaluation
• Market Information

Medical Devices Stream Menu

• About Medical Device Prequalification
• Documents A-Z
• Prequalified Medical Devices
• UNFPA listed Contraceptives acknowledged by WHO
• Prequalification Reports: Medical Devices
• Medical Devices Under Assessment
• Medical devices eligible for Prequalification
• Prequalification Procedure and Fees: Medical Devices
• Timelines for Medical Devices
• Post-Prequalification Procedures and Fees for Medical Devices
• Guidance Documents for Medical Devices

Medicines Stream Menu

• About Medicines Prequalification
• What We Do
• Documents A-Z
• Prequalification Pipeline
• Prequalified Lists
• FPPs and APIs Eligible for Prequalification ("EOIs")
• Prequalification Procedures & Fees: FPPs, APIs & QCLs
• Post-prequalification Procedures & Fees: APIs, FPPs, QCLs
• Prequalification Reports
• Collaborative Procedures for Accelerated Registration
• Guidance Documents
• Prequalification of Biotherapeutic Products
• Support to Manufacturers, CROs and QCLs
• Risk Assessment
• Market Information
• eCTD

Vaccines Stream Menu

• About Vaccines Prequalification
• What We Do
• Documents A-Z
• List of Prequalified Vaccines
• Vaccines Eligible for WHO Prequalification
• Prequalification Procedures & Fees
• Post-prequalification Procedures
• Guidance Documents
• Prequalification Reports
• Emergency Use Listing Procedure
• Market Information
• Risk Assessment - Snake Antivenom
• eCTD

VCP Stream Menu

• About Vector Control Products Prequalification
• What We Do
• Documents A-Z
• List of Prequalified Vector Control Products
• Prequalification Pipeline
• Prequalification Procedures & Fees
• Post-prequalification Procedures & Fees
• Prequalification reports
• List of Vector Control Active Ingredients
• WHO Specifications for Pesticides
• Guidance Documents
• Expert Advisory Groups

Inspection Services Stream Menu

• About Inspection Services
• What We Do
• Documents A-Z
• Inspection Services Procedures
• WHO Public Inspection Reports (WHOPIRs)
• Notice of Concern

42nd Invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification Unit (PQT)

News

27 July, 2026 - 00:12 (CEST)

M

The following APIs were added:

•APIs for products used in the treatment of sickle cell disease

• Hydroxyurea

Related Documents

M

43rd Invitation to manufacturers of Active Pharmaceutical Ingredients (API) to submit an Expression of Interest (EOI) for API evaluation to the WHO Prequalification Unit (PQT)pdf

Latest News

9 - 12 November, 2026 - 08:00 - 08:00 (CET)

SAVE THE DATE - 2026 Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers

1 October, 2026 - 08:00 (CEST)

WHO PQT launches eCTD submissions through the ePQS Portal

30 September, 2026 - 17:11 (CEST)

PQT/AMD newsletter - Q3 2026, Issue 54 is now available

29 September - 10 October, 2026 - 09:29 - 18:00 (CEST)

New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices

25 September, 2026 - 16:06 (CEST)

PQ Webinar: Launch of WHO Prequalification of Medical Devices

Featured News

9 - 12 November, 2026 - 08:00 - 08:00 (CET)

SAVE THE DATE - 2026 Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers

1 October, 2026 - 08:00 (CEST)

WHO PQT launches eCTD submissions through the ePQS Portal

7 August, 2026

2 additional tests listed under the EUL for IVDs

12 June, 2026 - 09:00 (CEST)

Call for public consultation – WHO’s Procedure for prequalification of vaccines

10 February, 2026 - 08:00 (CET)

ePQS Mandatory Use announced – 11 May 2026

About us

• History & Mission
• What We Do
• Funding
• Key performance indicators

Site map

• Events
• News
• Faq

WHO Links

• World Health Organization (WHO)
• WHO Essential Medicines and Health Products
• WHO Global Malaria Programme
• WHO Medical Devices
• WHO Medicines Quality Assurance
• WHO Regulation and Prequalification

Privacy Legal Notice

©2023WHO